Yıldırım, H. C.Güven, D. C. C.Aktepe, O. H.Yılmaz, F.Aktaş, B. Y.Güner, G.Dizdar, O.Aksoy, S.Erman, M.Yalçın, S.Kılıçkap, Saadettin2022-12-212022-12-212022Yildirim, H. C., Guven, D. C. C., Aktepe, O. H., Yilmaz, F., Aktas, B. Y., Guner, G., ... & Kilickap, S. (2022). 773P Differences between hyperprogressive disease and progressive disease in patients receiving immunotherapy. Annals of Oncology, 33, S894-S895.0923-75341569-8041http://dx.doi.org/10.1016/j.annonc.2022.07.899https://hdl.handle.net/20.500.12713/3749Differences between hyperprogressive disease and progressive disease in patients receiving immunotherapyeninfo:eu-repo/semantics/openAccessArticle337S894S895WOS:000866211601044Q110.1016/j.annonc.2022.07.899